A total of 15 Rhodococcus erythropolis strains were characterized as antibiotic producers and classified into three groups according to their antibiotic spectrum and growth compatibility (strains within a group did not inhibit each other's growth). Each of the antibiotic groups exhibited antibiotic activity against a taxonomically different breadth of bacteria: Group I exhibited antibiotic activity against a broad range of Gram-positives; Group II, mainly against the genus Rhodococcus and some other Gram-positives; and Group III, particularly against R. erythropolis. The antibiotic compounds of the strains belonging to Groups I and II were partially purified from liquid culture media. It was found that each group produces distinct antibiotics. In contrast to the diversity of antibiotic activity, the sequence of the 16S rRNA gene in the analyzed 1,440-nt region was found to be identical in all these 15 Rhodococcus strains. In addition to the antibiotic diversity in R. erythropolis strains, we elucidated the diversity in antibiotic-producing species of the genus Rhodococcus. Thus far, only a few antibiotic-producing strains have been reported in Rhodococcus; however, our results demonstrated that the genus comprises diverse antibiotic producers, and is a good source of new antibiotics.
In actinomycetes, numerous antibiotic producers have been identified. The genus Streptomyces, in particular, is well known for its remarkable antibiotic-producing ability. Many Streptomyces species produce various antibiotics. Other genera in the phylum Actinobacteria, such as Actinomadura 2) , Arthrobacter 8) , and Nocardia 23) have also been reported to produce antibiotics, though they have not been studied extensively. In the last few decades, the genus Rhodococcus, a member of Actinobacteria, has received considerable attention for its remarkable ability to degrade persistent chemicals such as polychlorinated biphenyls (PCBs) 14, 15) and nitrophenols 4, 11) ; the industrial application of nitrile hydratase that is synthesized by the members of this genus 13) has also been investigated. Previous research has also focused on the plant and mammalian pathogenic characteristics of some species belonging to this genus 3, 16) . Extensive research and considerable progress have been reported in these fields. However, the antibiotic-producing ability of rhodococci has not yet been studied extensively. To date, only a few antibiotic-producing Rhodococcus strains and the antibiotics that they produce have been reported 1, 6) . The rhodopeptin isolated from Rhodococcus sp. Mer-N1033 is a cyclic peptide that exhibits antibiotic activity against several fungal species, such as Candida albicans and Crytococcus neoformans, but not against bacteria 1) . Another antibiotic compound lariatin isolated from Rhodococcus sp. K01-B0171 is also a cyclic peptide that exhibits antibiotic activity, particularly against mycobacterial species 6) . In addition to the two strains mentioned above, the genus Rhodococcus is expected to include a number of potential antibiotic producers since its phylogenetic relatives also possess this ability. In this report, we investigated three groups of antibioticproducing R. erythropolis; these groups produced group-specific antibiotic compounds that exhibited antibiotic activity against a taxonomically different breadth of bacteria. In addition, we elucidated the diversity of the antibiotic-producing species in the genus Rhodococcus, which was previously not considered a major antibiotic producer.
Materials and Methods

Bacterial strains
The bacterial strains used in this study were obtained from the Japan Collection of Microorganisms (JCM, Wako, Japan), Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ, Braunschweig, Germany), Institute of Applied Microbiology (IAM, Tokyo, Japan), and our laboratory's microbial collections. Antibiotic-producing Rhodococcus strains (strains R01-R15) and other bacterial strains used as test strains (indicators of antibiotic activity; strains T01-T52) are listed in Table 1 .
Antibiotic activity test
In order to investigate antibiotic activity, a soft-agar assay was performed as follows. Fresh agar plates (diameter, 9 cm) were overlaid with 5 ml of soft-agar Luria-Bertani (LB) medium (0.5% agar) and seeded with a microbial test strain (2×10 5 -10 6 CFU/ml). After the agar had solidified, each plate was inoculated with 2 µl of a Rhodococcus strain (5×10 9 -1×10 10 CFU/ml) that formed colonies that were 3-4 mm in diameter. The plates were incubated for 1-2 days at 25°C, and the growth inhibition zone of each Rhodococcus colony was examined. The size of the growth-inhibition zone observed around the colonies for each Rhodococcus strain was typically dependent on the initial volume and density of the Rhodococcus inoculum and did not increase with an increase in the incubation period. We also tried testing for antibiotic activity by first inoculating an antibiotic-producing Rhodococcus strain followed by overlaying a test strain with soft agar and obtained the same results. Antibiotic activity in solid agar media was also investigated. An agar chip (7 mm square) was cut from the region flanking a streak- Strains  T37 T38 T39 T40 T41 T42 T43 T44 T45 T46 T47 T48 T49 T50 T51 cultured Rhodococcus colony and subsequently subjected to a softagar assay.
Extraction of antibiotic compounds from culture media
In order to recover antibiotic compounds from the liquid culture media, the supernatant of a 1.8-liter culture of the R. erythropolis strains was extracted with 450 ml of ethylacetate. The organic layer was then dried over Na2SO4 and evaporated dry in a rotary evaporator; subsequently, the residue was dissolved in a 1/200 volume of original culture by ethanol. Five microliters of the extract was transferred to paper disks (diameter, 8 mm), which after they had dried, were used in a soft-agar assay to examine antibiotic activity.
Purification of the antibiotic compounds
The antibiotic compounds recovered from the liquid culture media were subjected to high-performance liquid chromatography with diode array detection (HPLC-DAD). First, samples dissolved in ethanol were analyzed by reversed-phase HPLC (column, TSKgel ODS-80Ts, 4.6 mm I.D.×15 cm [TOSOH, Tokyo, Japan]; mobile phase, 65-75% methanol [0-8 min] and 90% methanol [8-12 min] ; flow rate, 1 ml/min; monitor wavelength, 220-600 nm). The eluted fractions were collected every 30 s, and each fraction was subjected to an antibiotic activity test. The fraction that retained antibiotic activity was identified, and the corresponding single peak of interest was collected by HPLC. Second, the collected sample was analyzed by size-exclusion chromatography (column, TSKgel G2000; 7.8 mm I.D.×30 cm [TOSOH] ; mobile phase, tetrahydrofuran; flow rate, 1 ml/min; monitor wavelength, 220-600 nm) using polystyrene as a molecular weight size standard (TOSOH).
Genetic analyses
Nucleotide sequencing of the 16S rRNA gene was performed using the Eu8F and Univ1492R primers, as reported previously 22) . 
Results and Discussion
Nearly 80 strains of the genus Rhodococcus were collected and screened for antibiotic-producing ability. During the first screening, Escherichia coli and species of Pseudomonas, Sinorhizobium, Streptomyces, Corynebacterium, Arthrobacter, and Rhodococcus were used as test strains. The results showed that 14 R. erythropolis strains and one R. globerulus strain formed growth-inhibition zones against at least one test strain on agar plates. Several other species of Rhodococcus also showed antibiotic activity in this growthinhibition test (see below). Because many strains of R. erythropolis were found to produce antibiotics, we focused on this species. Further, the 15 strains in this study-14 R. erythropolis strains and one R. globerulus strain-were selected since they exhibited common features (see below). The antibiotic properties of the 15 Rhodococcus strains (designated as R01-R15) were extensively analyzed using 52 test strains (T01-T52, Table 1 ). The test strains comprised 19 Gram-negative species and 32 Gram-positive species, including species belonging to the phyla Proteobacteria (the classes Alphaproteobacteria (T01-T05), Betaproteobacteria (T06-T11), and Gammaproteobacteria (T12-T16)), Bacteroidetes (T17, T18), Deinococcus-Thermus (T19), Firmicutes (T20-T23), and Actinobacteria (T24-T51); the test strains also included an yeast strain (T52).
As indicated in Table 1 , the 15 Rhodococcus strains tended to exhibit antibiotic activity against the Gram-positive species; however, they did not exhibit antibiotic activity against most of the Gram-negative species. Interestingly, all the R. erythropolis strains showed antibiotic activity against other R. erythropolis strains, for example, the type strain of R. erythropolis DSM 43066 (strain T45, see Table 1 ), -a member of the same species. Analysis of these data indicated that some strains, including R01-R05, share significantly similar antibiotic activities.
To understand antibiotic susceptibility and resistance among the Rhodococcus strains, a round robin competition was performed for the 15 strains ( Table 2 ). The Rhodococcus strains R01-R05, R06-R08, and R09-R15 did not interfere with each other's growth. These results clearly indicated that the 15 strains could be classified into three groups that each exhibited antibiotic activity against a taxonomically different breadth of bacteria (Tables 1 and 2 ). Group I comprised five strains (R01-R05) that exhibited antibiotic activity against a broad range of Gram-positives; Group II, three strains (R06-R08) with activity mainly against Rhodococcus and some other Gram-positives; and Group III, seven strains (R09- Rhodococcus strains indicated in the vertical axis were inoculated on agar plates and overlayed with soft agar containing the examinee indicated in the horizontal axis. +, ++, and +++, size of the growth inhibition zone (from the edge of Rhodococcus colony to the outer edge of the zone) <1 mm, 1 to 3 mm, and 3 mm<, respectively. Compatible growth seen among each group is shaded in gray.
R15) that exhibited antibiotic activity, particularly against R. erythropolis. The antibiotic Groups I and II showed similar antibiotic spectra however, some difference was seen between them. For example, Group I showed antibiotic activity against Sinorhizobium sp., Bacillus sp., Corynebacterium sp., Nocardioides sp., and Terrabacter sp. (Table 1, strains  T03, T20, T25, T30 , and T33), but Group II did not. In contrast, only Group II showed antibiotic activity against Flavobacterium sp. (Table 1 , strain T18). It is conceivable that the members of each group produce highly similar or identical antibiotic material(s). In general, each group demonstrated both growth inhibition against and susceptibility toward the other groups (Table 2 ). When two R. erythropolis strains from different groups were used for competition (softagar assay), the denser strain seemed always to win. In order to recover antibiotic compounds from the liquid culture media, the culture supernatant of the strains belonging to each of the three R. erythropolis groups was extracted with ethylacetate (see Materials and Methods). The extract was dissolved in ethanol and then subjected to an antibiotic activity test using the type strain of R. erythropolis (DSM 43066) as the test strain. Antibiotic activity was successfully detected in the culture media of strains belonging to Groups I and II. On the other hand, in Group III, antibiotic activity was not detected following extraction of the culture supernatant with either ethylacetate or another organic solvent such as dichloromethane or methanol/chloroform (1:1). This may be because the antibiotic compound produced by the Group III strains could not be extracted by any of these organic solvents or its activity was destroyed by organic solvents or other extraction procedures. The antibiotic compound produced by the Group I strains was also recovered from the autoclaved culture supernatant of the strains (121°C, 15 min), while in the case of the Group II strains, the antibiotic compound could not be recovered; however, both retained activity 1 h after incubation at 60°C. In the case of Group III (strain R09), the antibiotic activity was obtained from agar media (see Materials and Methods). An agar chip prepared from the region flanking the Group III colonies retained antibiotic activity; however, the activity was rapidly lost on incubation at 60°C. These observations demonstrating differences in temperature stability between the compounds support the notion that each of the three groups of R. erythropolis produces a different antibiotic compound.
The antibiotic compounds from Group I (strain R04, R. erythropolis JCM 6824) and Group II (strain R06, R. erythropolis DSM 11397) were partially purified by HPLC (see Materials and Methods). From the sample from strain R04 (Group I), a single peak that retained the antibiotic activity was identified at a retention time of 10.6 min, and it exhibited two DAD UV absorption maxima at 246 and 339 nm.
The peak showed an approximate molecular weight of 450 Da, as determined by subsequent size-exclusion chromatography. In the case of strain R06 (Group II), a single peak that had a retention time of 4.1 min, exhibited two DAD UV absorption maxima at 238 and 430 nm, and had an approximate molecular weight of 200 Da. The purified antibiotic compounds from strains R04 (Group I) and R06 (Group II) were gray and red-brown, respectively. By HPLC analyses, a single peak showing the same HPLC profile (retention time and absorption maxima) as that of the antibiotic compound of strain R04 was found in each of the Group I strains; however, it was not seen in any of the Group II or III strains. Similarly, a single peak showing the same HPLC profile as that of strain R06 was found in each of the Group II strains, but not in any of the Group I or III strains. Thus, these results strongly indicated that strains belonging to the same group produce the same antibiotic, and that each of the three groups of R. erythropolis produces a particular antibiotic. The characteristics of the antibiotic compounds from the three groups of Rhodococcus are summarized in Table 3 .
Although the antibiotic compound produced by the Group III strains was not recovered in this study, it appeared to have some characteristics of a certain type of antibiotic known as bacteriocin. Bacteriocins are antibiotic peptide/proteins synthesized by the ribosome that are active mainly against close relatives of the strains that produce them. Bacteriocins have been isolated from various Gram-negative and Gram-positive bacteria 7, 20) ; however, thus far, they have not been reported in the genus Rhodococcus. The antibiotic compound produced by the Group III R. erythropolis strain, which is heat labile and showed a narrow antibiotic spectrum, may be a bacteriocin. Further studies are needed to identify the compound as a Class III bacteriocin (a large, heat-labile protein), according to the classification proposed by Klaenhammer 12) . The antibiotic spectra of the three groups are apparently different from those of two previously reported antibiotics obtained from Rhodococcus strains (neither of which has been identified to the species level): rhodopeptin showed antibiotic activity against fungi (no activity against bacteria) 1) , while lariatin showed antibiotic activity against mycobacteria 6) . Mycobacteria did not exhibit susceptibility to any of the antibiotics produced by the Rhodococcus groups in this study (Table 1, T28 ). This suggests that the antibiotics produced by all the three R. erythropolis groups were different from those of other Rhodococcus strains reported previously.
The phylogenetic relationships between the 15 strains were determined by analysis of the 16S rRNA gene 22) . In contrast to the differences found in antibiotic activity, the nucleotide sequences of the 16S rRNA gene of the R. erythropolis strains and the R. globerulus strain were found to be 10) reported that an antagonistic factor promotes biological diversity, and Kerr et al. 9) and Huisman and Weissing 5) showed that nonhierarchical competitive relationships promote diversity. Moreover, the antagonistic, nonhierarchical competitive relationship observed in the genus Rhodococcus might also promote or support the diversity of rhodococci in natural environments.
By focusing solely on R. erythropolis, we demonstrated the diversity of antibiotic-producing rhodococci. In addition, we identified other antibiotic-producing strains of species such as R. ruber DSM 43338, R. rhodnii DSM 43336, and R. zopfii DSM 44189 that exhibited antibiotic spectrums different from those of any of the three groups of R. erythropolis. R. ruber showed antibiotic activity against Sinorhizobium (T03), Bradyrhzobium (T04), and Arthrobacter (T24); R. rhodnii, against Arthrobacter (T24), R. fascians (T36), and R. rhodochrous (T37); and R. zopfii, against Bradyrhzobium (T04) and Escherichia (T13). None of these strains showed antibiotic activity against R. ertythropolis. Thus, these results indicate that many antibiotic-producing rhodococci exist in the environment and suggest that the genus Rhodococcus is a good source of new antibiotics and their corresponding genes. This is the first study demonstrating that R. erythropolis strains exhibit three distinct antibiological activities; this is also the first study demonstrating that there is diverse antibiotic production in rhodococci. Previously, members of this genus were not regarded as good antibiotic producers. Most interestingly, our study demonstrated that each of the three groups of R. erythropolis exhibited antibiotic activity against a taxonomically different breadth of bacteria (different antibiotic spectra). Further, it was found that although the three Rhodococcus groups were closely related phylogenetically, the groups inhibited each other's growth by producing group-specific weapons. It is not clear why these phylogenetically close relatives compete with each other; however, it is hypothesized that the competition for nutrients among microorganisms that share similar characteristics (such as catabolic, assimilative, and survival) is extremely severe. Therefore, phylogentically close relatives might be formidable rivals in the environment. Further investigation of these strains, the antibiotic compounds, and the corresponding genes by using recently developed random transposon mutagenesis, host-vector systems, and gene expression in Rhodococcus 17, 21) is required to understand their function, origin, and ecological role in the environment.
